DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/dtpvd9/obesity) has announced the addition of the "Obesity Partnering 2009-2014" report to their offering.
The Obesity Partnering 2009-2014 report provides understanding and access to the obesity partnering deals and agreements entered into by the world's leading healthcare companies.
- Trends in obesity partnering deals
- Top obesity deals by value
- Deals listed by company A-Z, industry sector, stage of development, technology type
The report provides an analysis of obesity partnering deals. The majority of deals are discovery or development stage, whereby the licensee obtains a right or an option right to license the licensor's obesity technology. These deals tend to be multi-component, starting with collaborative R&D and commercialization of outcomes.
Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the details in terms of how payments are triggered - contract documents provide this insight where press releases do not.
This data-driven report contains over 130 links to online copies of actual obesity deals and contract documents as submitted to the Securities and Exchange Commission by companies and their partners, where available. Contract documents provide the answers to numerous questions about a prospective partner's flexibility on a wide range of important issues, many of which will have a significant impact on each party's ability to derive value from the deal.
For more information, visit http://www.researchandmarkets.com/research/dtpvd9/obesity.